1.
Cutis
; 107(4): 216-220, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34096849
RESUMO
Apremilast is a small-molecule biologic approved by the US Food and Drug Administration (FDA) for use in plaque psoriasis, psoriatic arthritis, and Behçet disease. Although apremilast is seemingly a less favorable choice for treating psoriasis in the era of injectable biologics, the drug is an important option for patients in the military. In this article, we review on-label indications and off-label uses for apremilast; highlight the importance of apremilast for managing psoriasis in the military population; and propose other patient populations in whom the use of apremilast is favorable. We also present a case report that highlights and embodies the benefit of apremilast for military service members.
Assuntos
Artrite Psoriásica , Militares , Anti-Inflamatórios não Esteroides/uso terapêutico , Artrite Psoriásica/tratamento farmacológico , Humanos , Talidomida/análogos & derivados , Talidomida/uso terapêutico
2.
Pediatr Dermatol
; 37(6): 1149-1150, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33283924